2,4-Dibromo-6-(trifluoromethyl)aniline, 97.0%, 100g

(3aR,6R,6aR)-2,2-Dimethyl-6-vinyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-one, 98%, 500mg

6-(2,6-Dichloro-phenyl)-2-[4-(2-diethylaMino-ethoxy)-phenylaMino]-8-Methyl-8H-pyrido[2,3-d]pyriMidin-7-one, 99%, 1mg

2,3-Dichloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 25g

Estramustine, 98%, 250mg

Methyl 2-(4-(tert-butyl)phenyl)-2-hydroxyacetate, 98%, 250mg

Screw top bottle DURAN® stainless steel GL 45 UN-approved transport bottle, 1 Piece

6-(cyclopentyloxy)nicotinic acid, 95.0%, 1g

N-(p-Toluenesulfonyl)-ethylene diamine, 90.0%, 25g

[5-Methyl-2-(3-methylbutoxy)phenyl]boranediol, 98%, 250mg

GC capillary column ROTI®Cap-5, 60 m, 0.32 mm, 1.00 µm, 1 Piece(s)

2-Cyano-5-iodopyridine, 95.0%, 5g

5,10-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphtho[1,2-c:5,6-c']bis([1,2,5]thiadiazole)>98.0%(HPLC)100mg